Clinical Trial: PH Sensitive MRI Based Resections of Glioblastoma
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Glioblastoma
Study Type: INTERVENTIONAL
Official Title: PH Weighted Chemical Exchange Saturation Transfer Based Surgical Resections of Glioblastoma
Brief Summary:
Standard of care therapy and all FDA approved adjuvant therapy for glioblastoma continue to provide < 12-month progression free survival (PFS) and < 24-month overall survival (OS).Standard of care therapy continues to be defined by the volume of tumor that enhances with gadolinium on standard magnetic resonance imaging (MRI).The investigators have identified a significant tumor burden in non-enhancing (NE) regions beyond the contrast-enhancing (CE) portion of tumor.Furthermore, the investigators have adapted…
Read more